Delays in recommendation of remdesivir for patients with COVID-19 shaped antimicrobial policy in hospitals world over

NewsLeave a comment

Delays in recommendation of remdesivir for patients with COVID-19 adversely shaped antimicrobial policy in hospitals around the world, preventing patients from receiving timely remdesivir says The Lancet Respiratory Medicine, at the 30th Conference on Retroviruses and Opportunistic Infections (CROI). Remdesivir is a viral RNA polymerase inhibitor. An individual patient data meta-analysis has added relevant scientific evidence…

Study suggests dapivirine vaginal ring is safe to use as HIV prevention during breastfeeding

Press ReleaseLeave a comment

A monthly vaginal ring containing the antiretroviral drug dapivirine – an HIV prevention method that has been approved in several African countries and recommended by the World Health Organization (WHO) –appears to be safe when used during breastfeeding, suggest results of a Phase IIIb open-label study presented today at the Conference on Retroviruses and Opportunistic…

Copernicus Atmosphere Monitoring Service shows first Saharan Dust transport of 2023

NewsLeave a comment

Aerosol forecasts from the Copernicus Atmosphere Monitoring Service show the first large-scale Saharan dust transport of 2023. An episode of a long-range Saharan dust transport has been crossing the Iberian Peninsula and will continue across France towards northern and central Europe in the coming days. The Copernicus Atmosphere Monitoring Service (CAMS) is tracking the long-range…

Cheap antibiotic to avert 2 million deaths per year from Sepsis for women who have a Vaginal Birth in resource limited settings

NewsLeave a comment

A single dose of a low-cost, generic, oral antibiotic called azithromycin, could prevent life threatening sepsis during child birth in up to 2 Million women per year a study shows. In a randomized, placebo-controlled study published in the New global maternal health research on February 9th, 2023, researchers found that a single 2-g oral dose of azithromycin given…

Most comprehensive study to date provides evidence on natural immunity protection by COVID-19 variant and how protection fades over time

Press ReleaseLeave a comment

For someone previously infected with COVID-19, their risk of hospitalization or death is 88% lower for at least 10 months compared to those who had not been previously infected, according to a systematic review and meta-analysis published in The Lancet.   The analysis also suggests that the level and duration of protection against reinfection, symptomatic…